These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 29237470)
1. Gimatecan exerts potent antitumor activity against gastric cancer in vitro and in vivo via AKT and MAPK signaling pathways. Chen Z; Liu Z; Huang W; Li Z; Zou J; Wang J; Lin X; Li B; Chen D; Hu Y; Ji J; Gao J; Shen L J Transl Med; 2017 Dec; 15(1):253. PubMed ID: 29237470 [TBL] [Abstract][Full Text] [Related]
2. A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo. Zou J; Li S; Chen Z; Lu Z; Gao J; Zou J; Lin X; Li Y; Zhang C; Shen L Cell Death Dis; 2018 May; 9(6):661. PubMed ID: 29855512 [TBL] [Abstract][Full Text] [Related]
3. EPHA2 blockade reverses acquired resistance to afatinib induced by EPHA2-mediated MAPK pathway activation in gastric cancer cells and avatar mice. Chen Z; Liu Z; Zhang M; Huang W; Li Z; Wang S; Zhang C; Dong B; Gao J; Shen L Int J Cancer; 2019 Nov; 145(9):2440-2449. PubMed ID: 30957241 [TBL] [Abstract][Full Text] [Related]
4. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways. Zhang Q; Wang X; Cao S; Sun Y; He X; Jiang B; Yu Y; Duan J; Qiu F; Kang N Biomed Pharmacother; 2020 Aug; 128():110245. PubMed ID: 32454290 [TBL] [Abstract][Full Text] [Related]
5. Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer. Zhu Y; Tian T; Zou J; Wang Q; Li Z; Li Y; Liu X; Dong B; Li N; Gao J; Shen L BMC Cancer; 2015 Nov; 15():894. PubMed ID: 26560145 [TBL] [Abstract][Full Text] [Related]
6. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer. Huang S; Wang D; Zhang S; Huang X; Wang D; Ijaz M; Shi Y Cancer Chemother Pharmacol; 2017 Oct; 80(4):685-696. PubMed ID: 28779263 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells. Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Wang NJ; Zhao RJ; Zhou SF Drug Des Devel Ther; 2015; 9():487-508. PubMed ID: 25609923 [TBL] [Abstract][Full Text] [Related]
8. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways. Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028 [TBL] [Abstract][Full Text] [Related]
9. Anti-gastric cancer effect of Salidroside through elevating miR-99a expression. Yang L; Yu Y; Zhang Q; Li X; Zhang C; Mao T; Liu S; Tian Z Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3500-3510. PubMed ID: 31432697 [TBL] [Abstract][Full Text] [Related]
10. Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer. Lu J; Li G; He K; Jiang W; Xu C; Li Z; Wang H; Wang W; Wang H; Teng X; Teng L J Transl Med; 2015 Feb; 13():42. PubMed ID: 25638174 [TBL] [Abstract][Full Text] [Related]
11. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells. Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376 [TBL] [Abstract][Full Text] [Related]
12. Recombinant human insulin-like growth factor-binding protein 3 inhibits tumor growth and targets the Akt pathway in lung and colon cancer models. Alami N; Page V; Yu Q; Jerome L; Paterson J; Shiry L; Leyland-Jones B Growth Horm IGF Res; 2008 Dec; 18(6):487-96. PubMed ID: 18502161 [TBL] [Abstract][Full Text] [Related]
13. Shikonin inhibits proliferation, migration, invasion and promotes apoptosis in NCI-N87 cells via inhibition of PI3K/AKT signal pathway. Jia L; Zhu Z; Li H; Li Y Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2662-2669. PubMed ID: 31257936 [TBL] [Abstract][Full Text] [Related]
14. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer. Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694 [TBL] [Abstract][Full Text] [Related]
15. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway. Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811 [TBL] [Abstract][Full Text] [Related]
16. Esculetin exerts antitumor effect on human gastric cancer cells through IGF-1/PI3K/Akt signaling pathway. Wang G; Lu M; Yao Y; Wang J; Li J Eur J Pharmacol; 2017 Nov; 814():207-215. PubMed ID: 28847482 [TBL] [Abstract][Full Text] [Related]
17. Crocin Combined with Cisplatin Regulates Proliferation, Apoptosis, and EMT of Gastric Cancer Cells via the FGFR3/MAPK/ERK Pathway Li Y; Guo QJ; Chen R; Zhao L; Cui X; Deng Y; Luo YS Curr Cancer Drug Targets; 2024; 24(8):835-845. PubMed ID: 37718528 [TBL] [Abstract][Full Text] [Related]
18. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits. Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187 [TBL] [Abstract][Full Text] [Related]
19. Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway. Yang ZP; Zhao Y; Huang F; Chen J; Yao YH; Li J; Wu XN World J Gastroenterol; 2015 Sep; 21(36):10385-99. PubMed ID: 26420965 [TBL] [Abstract][Full Text] [Related]
20. Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK/ERK and PI3K/AKT pathways via distinct mechanisms. Su X; Shen Z; Yang Q; Sui F; Pu J; Ma J; Ma S; Yao D; Ji M; Hou P Theranostics; 2019; 9(15):4461-4473. PubMed ID: 31285773 [No Abstract] [Full Text] [Related] [Next] [New Search]